Bioclinica
1 known investors
Clario provides clinical trial endpoint technologies and solutions—including software, connected devices, and AI across cardiac safety, eCOA, medical imaging, precision motion, and respiratory—for pharmaceutical sponsors, clinical trial sites, and CROs. It supports site-based, hybrid, and decentralized drug trials across more than 100 countries.